Advancing Vaccines
For Better Lives
Welcome to Valneva
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Our focused pipeline includes the only Lyme disease vaccine candidate in clinical development today, a single-shot chikungunya vaccine candidate, and an inactivated vaccine candidate against COVID-19.
Check out our 2020 Annual Business Report: https://www.valnevaannualbusinessreport.com/
